Skip to main content
A Multicenter Phase I/II Study of Relapse Prophylaxis with Nilotinib after Hematopoietic Cell Transplantation (HCT) for High-Risk Philadelphia Chromosome-Positive (Ph plus ) Leukemias Carpenter, P. A., Johnston, L., Fernandez, H., Radich, J., Mauro, M. J., Flowers, M. D., Martin, P. J., Gooley, T. ELSEVIER SCIENCE INC. 2015: S274–S276

View details for DOI 10.1016/j.bbmt.2014.11.435

View details for Web of Science ID 000348633000391